{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T10:39:31Z","timestamp":1721212771051},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.endonu.2015.12.009","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:15:17Z","timestamp":1457482517000},"page":"212-219","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adrenocortical carcinoma: Retrospective analysis of the last 22 years"],"prefix":"10.1016","volume":"63","author":[{"given":"Daniela","family":"Guelho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2015.12.009_bib0175","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.endonu.2015.12.009_bib0180","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.endonu.2015.12.009_bib0185","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejca.2009.12.007","article-title":"The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation","volume":"46","author":"Lughezzani","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.endonu.2015.12.009_bib0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ecl.2015.02.007","article-title":"Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis","volume":"44","author":"Nakamura","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endonu.2015.12.009_bib0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1530\/eje.0.1450335","article-title":"Discerning malignancy in adrenocortical tumors: are molecular markers useful?","volume":"145","author":"Wachenfeld","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.12.009_bib0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1507\/endocrj.K07-079","article-title":"Immunohistochemistry of a proliferation marker Ki67\/MIB1 in adrenocortical carcinomas: Ki67\/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas","volume":"55","author":"Morimoto","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.endonu.2015.12.009_bib0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12672-011-0088-0","article-title":"The Weiss score and beyond \u2013 histopathology for adrenocortical carcinoma","volume":"2","author":"Papotti","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.endonu.2015.12.009_bib0210","first-page":"155","article-title":"Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases","volume":"23","author":"Macfarlane","year":"1958","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.endonu.2015.12.009_bib0215","first-page":"885","article-title":"Deficits in the management of patients with adrenocortical carcinoma in Germany","volume":"107","author":"Johanssen","year":"2010","journal-title":"Deutsch Arztebl Int"},{"key":"10.1016\/j.endonu.2015.12.009_bib0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","article-title":"Adrenocortical carcinoma: diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.endonu.2015.12.009_bib0225","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.12.009_bib0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-0032-1331743","article-title":"Is there a role for laparoscopic adrenalectomy in patients with suspected adrenocortical carcinoma? A critical appraisal of the literature","volume":"45","author":"Jurowich","year":"2013","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.endonu.2015.12.009_bib0235","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.eururo.2010.01.036","article-title":"Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer","volume":"57","author":"Porpiglia","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.endonu.2015.12.009_bib0240","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00268-010-0532-2","article-title":"Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma","volume":"34","author":"Miller","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.endonu.2015.12.009_bib0245","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group","volume":"25","author":"Icard","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.endonu.2015.12.009_bib0250","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/SLA.0b013e3182367ac3","article-title":"Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma","volume":"255","author":"Reibetanz","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.endonu.2015.12.009_bib0255","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00423-011-0866-8","article-title":"Adrenocortical carcinoma: effect of hospital volume on patient outcome","volume":"397","author":"Lombardi","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.endonu.2015.12.009_bib0260","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.endonu.2015.12.009_bib0265","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.12.009_bib0270","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/ERC-12-0368","article-title":"Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells","volume":"20","author":"Hescot","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.endonu.2015.12.009_bib0275","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2015.12.009_bib0280","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2010-0803","article-title":"Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers","volume":"95","author":"Fassnacht","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.12.009_bib0285","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1210\/jc.2008-0579","article-title":"Adjuvant mitotane for adrenocortical cancer \u2013 a recurring controversy","volume":"93","author":"Huang","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.12.009_bib0290","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2015.12.009_bib0295","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/BF03344148","article-title":"Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane","volume":"29","author":"Sperone","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endonu.2015.12.009_bib0300","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jc.2010-2676","article-title":"Plasma concentrations of o,p\u2032DDD, o,p\u2032DDA, and o,p\u2032DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study","volume":"96","author":"Hermsen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.12.009_bib0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-11-0557","article-title":"High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up","volume":"166","author":"Mauclere-Denost","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.12.009_bib0310","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/1097-0142(20010915)92:6<1385::AID-CNCR1461>3.0.CO;2-2","article-title":"Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p\u2032DDD) levels on the treatment of patients with adrenocortical carcinoma","volume":"92","author":"Baudin","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.endonu.2015.12.009_bib0315","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.endonu.2015.12.009_bib0320","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12672-011-0094-2","article-title":"Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?","volume":"2","author":"Baudin","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.endonu.2015.12.009_bib0325","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1530\/EJE-07-0723","article-title":"Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma","volume":"158","author":"Hermsen","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2015.12.009_bib0330","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.12.009_bib0335","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2013-2856","article-title":"Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma","volume":"99","author":"Else","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2015.12.009_bib0340","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/1097-0142(19800601)45:11<2880::AID-CNCR2820451127>3.0.CO;2-#","article-title":"A clinical and pathological study of adrenocortical carcinoma: therapeutic implications","volume":"45","author":"Hogan","year":"1980","journal-title":"Cancer"}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092216000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092216000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T09:24:53Z","timestamp":1536917093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092216000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1575092216000243"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2015.12.009","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenocortical carcinoma: Retrospective analysis of the last 22 years","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endonu.2015.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEEN. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}